Tuesday, September 15, 2026

North Korea’s Upcoming Elections: What to Expect from the 15th Supreme People’s Assembly Candidates

North Korea is preparing for the 15th Supreme People's Assembly elections with excitement, though critics view the process as largely symbolic.

Tracking Teacher Mental Health: U.S. and Japan vs. South Korea

South Korea's Ministry of Education discusses mandatory mental health screenings for teachers after a tragic incident.

North Korea Inaugurates First Stage of Tanchon Power Plant Amid Ongoing Power Supply Challenges

North Korea's Dancheon Power Plant's first phase is complete, enhancing power supply amid chronic shortages and showcasing self-reliance.

Tag: development

Inventage Lab Selected for Global TIPS Program, Accelerating Late-Stage Development of Addiction Treatment

Inventis Lab's long-acting drug IVL3004 for addiction treatment has been selected for the Global TIPS research project by the Ministry of SMEs.

Alteogen Signs $365 Million License Deal With Global Pharma Company for SC Platform Technology

Alteogen has signed an exclusive licensing agreement with a global pharmaceutical company for the development of subcutaneous biopharmaceuticals.

Unlocking Game Development: Join OpenAI’s Game Builders Seoul Hackathon with Codex!

OpenAI collaborates with Com2us and game developer Song Jae-kyung for a hackathon using the coding agent Codex.

AI-Driven Preclinical Platform: Revolutionizing Infectious Disease Treatment and Vaccine Development by 2030

An AI-based digital preclinical platform is being developed to expedite the creation of treatments and vaccines for emerging infectious diseases.

What Makes QP101 the Next Big Breakthrough in Cancer Treatment?

QP101, a next-gen antibody-drug conjugate by Curient, is highlighted as a notable drug development strategy by AACR.

Celltrion accelerates mechanism diversification strategy, expands autoimmune disease portfolio

Celltrion accelerates the development of biosimilars for autoimmune disease treatments, expanding its portfolio for long-term growth.

Penetrium Bio to unveil U.S. Phase 2 strategy at global symposium

Penetrium Bio will unveil its Phase 2 clinical development strategy for the next-gen cancer drug Penetrium at a global symposium next month.

Daedeok Innopolis expands biotech collaboration with Johns Hopkins and Harvard

The Daedeok Special Zone Foundation held a seminar on Korea-U.S. advanced bio-technology cooperation in Daejeon.

HLB Panagene Signs Exclusive PNA Distribution Agreement in Singapore With Roche Affiliate

HLB Panajin signs exclusive distribution deal for PNA with Roche Group's subsidiary, advancing its drug development efforts.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Revolutionary AI Breakthrough: How KAIST’s New Tech Reduces Sensory Confusion in Multimodal AI

A key technology has been developed to end the era of AI claiming to hear what it cannot and see what is not there.

Hyundai Motor Group Recruits Former Samsung Executive to Lead Autonomous Driving AI Development

Hyundai Motor Group appoints Kwon Jeong-hyun as head of Autonomous Driving Development, enhancing its autonomous mobility technologies.

Revolutionizing Material Development: How LG CNS and AI Are Slashing Time and Costs

LG CNS joins a global initiative with NVIDIA and Meta to enhance new material development using AI, cutting timelines significantly.

Pharos iBio Targets Global Licensing Deals, Expands U.S. and European Market Strategy

Pharos iBio aims to secure licensing deals and enhance its AI drug discovery platform for rare diseases, targeting global partnerships.

Top News

- Our Sponsors Ad -

Follow us